Combination of cyclosporin A and buthionine sulfoximine (BSO) as a pharmacological strategy for circumvention of multidrug resistance in small cell lung cancer cell lines selected for resistance to doxorubicin
Volume:
7
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/0169-5002(91)90425-6
Date:
December, 1991
File:
PDF, 142 KB
english, 1991